EMT reversal in human cancer cells after IR knockdown in hyperinsulinemic mice
Zara Zelenko(Icahn School of Medicine at Mount Sinai), Derek LeRoith(Icahn School of Medicine at Mount Sinai), Deepali Sachdev(University of Minnesota), Emily J. Gallagher(Icahn School of Medicine at Mount Sinai), Anupma Nayak(University of Pennsylvania), Douglas Yee(University of Minnesota Medical Center), Irini Markella Antoniou(Icahn School of Medicine at Mount Sinai)
Cited by 32
Related Papers
Effect of Pembrolizumab Plus Neoadjuvant Chemotherapy on Pathologic Complete Response in Women With Early-Stage Breast Cancer
|JAMA Oncology|2020|707
Durvalumab with olaparib and paclitaxel for high-risk HER2-negative stage II/III breast cancer: Results from the adaptively randomized I-SPY2 trial
|Cancer Cell|2021|330
Association of Event-Free and Distant Recurrence–Free Survival With Individual-Level Pathologic Complete Response in Neoadjuvant Treatment of Stages 2 and 3 Breast Cancer
|JAMA Oncology|2020|225
ΔNp63-driven recruitment of myeloid-derived suppressor cells promotes metastasis in triple-negative breast cancer
|Journal of Clinical Investigation|2018|200